How often does this podcast release new episodes?

This podcast updates bi-weekly.

Where can I listen to this podcast?

This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Prescription for Better Access

Claim This Podcast

by Mark Hansan and Dr. Scott Howell

5.0(39 reviews)

39 episodes

Updated Bi-weekly

Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Authority

Beta

FairBased on show quality, social media presence, reviews, charts, and more

Quality49

Social0

YouTube68

Engagement51

Learn more

Podcast Overview

With pharmaceutical and biotech manufacturers launching more high-cost specialty drugs and the insurance industry increasing the use of more restrictive barriers to access, those who need these medicines—the patients themselves—are caught in the middle, not only shouldering the cost of higher copays and deductibles, but for many, rationing or even abandoning treatment altogether. While manufacturers invest in programs to help navigate the challenges impeding access and affordability, the entire healthcare industry can agree -- the status quo is unsustainable. There has to be a better way. And two industry veterans have joined forces to co-host a new interview-focused podcast to help shape the future of patient access and affordability.

Language

🇺🇲

Publishing Since

1/23/2023

Visit Website View on Apple Podcasts RSS Feed

🇺🇸 Charts #3

Outreach generated

Apple 142

Spotify 827

Instant mention tracking

Perfect fit!

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

Podcast Authority

Beta

FairBased on show quality, social media presence, reviews, charts, and more

Quality49

Social0

YouTube68

Engagement51

Learn more

Excellent Areas

Good Performance

Growth Opportunities

excellent

Episode Length

38 minutes

Performing excellently!

good

Show Experience

31 episodes over 2.5 years

Recommendations available

Unlock the full report to see detailed tips

needs improvement

Publishing Consistency

Every 29 days

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

• YouTube presence analysis
• Social media reach metrics
• RSS compliance scoring
• Podcast 2.0 features
• Technical standards

What's Included in Your Full Report

Detailed Analytics

Complete breakdown of all 19 authority metrics
Personalized recommendations for each metric
Industry benchmarks and comparisons
Technical RSS feed analysis and compliance scoring

Growth Strategies

Step-by-step action plans for improvement
Quick wins to boost your score immediately
Pro tips from successful podcasters

Get your free podcast insights report

See how your show performs across every key metric

Instant delivery

No spam

Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

4 verified contact emails on file for Prescription for Better Access

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

July 15, 2026

An Interview with Kathryn Carey, President, Optum Rx Pharmacy Benefit Manager

In this episode, we sit down with Kathryn Carey, President, Optum Rx Pharmacy Benefit Manager, to discuss one of the most significant shifts underway in the pharmacy benefit management industry. We explore their new transparent, fixed-fee model, what is driving it, and what it actually means for patients, providers, pharmacies, and manufacturers. We also examine Optum Rx’s digital tools and how they are reshaping the prescribing experience, and the broader effort to reduce friction in patient access. At its core, this is a conversation about whether these changes are early stages of a new model for how medicines are accessed and paid for in the United States. Optum Rx New PMPM Model PBMs Explained PreCheck Prior Authorization PreCheck MyScript Shop MyScript Price Edge Price Wise Savings IQ Critical Drug Affordability Program Questions or comments? Email us at comments@prescriptionforbetteraccess.com. Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.

May 20, 2026

Inside PhRMA: An Interview with Stephen Ubl, President and CEO, PhRMA

In this episode, we interview Stephen Ubl, President and CEO of PhRMA, to discuss what is happening across the industry at a time of significant change. We talk about biopharma’s continued commitment to innovation, what member companies are doing to help patients access medicines more directly, and how new tools from the organization are supporting patient affordability. We also cover the impact of policies like the IRA and MFN, along with the growing focus on PBM reform and other structural challenges in the system. It is a wide-ranging conversation about where the industry is headed and what it will take to ensure the country continues to lead the world in bringing new treatments to patients in need. <ul> <li><a href="https://www.linkedin.com/in/steveubl/">Steve Ubl, CEO of PhRMA</a></li> <li><a href="https://phrma.org/">PhRMA</a></li> <li><a href="https://www.phrma.org/resources/phrma-president-ceo-steve-ubl-announces-plans-for-leadership-transition">PhRMA Leadership Transition</a></li> <li><a href="https://phrma.org/resources/phrma-announces-major-actions-as-part-of-industry-s-commitment-to-american-patients-and-workers">PhRMA 3 Announcements</a></li> <li><a href="https://www.phrma.org/resources/mat-one-pager">Medicine Assistance Tool (MAT)</a></li> <li><a href="https://americasmedicines.com/">America’s Medicines</a></li> <li><a href="https://www.jimcollins.com/article_topics/articles/building-companies.html">Jim Collins, Building Companies to Last</a></li> <li><a href="https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-secures-landmark-settlement-express-scripts-lower-drug-costs-american-patients">FTC Settlement with Express Scripts</a></li> <li>IQVIA Data: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC13090851/">Prior Authorization and Associated Delays and Denials of Branded Medication Dispensation</a></li> <li><a href="https://www.congress.gov/crs-product/LSB11319">Most Favored Nation Drug Pricing</a></li> <li><a href="https://www.hrsa.gov/opa">340B Drug Pricing Program</a></li> <li>New York Times: <a href="https://www.nytimes.com/2022/09/24/health/bon-secours-mercy-health-profit-poor-neighborhood.html">How a Hospital Chain Used a Poor Neighborhood to Turn Huge Profits</a></li> <li><a href="https://phrma.org/blog/40-years-of-hatch-waxman-what-is-the-hatch-waxman-act">Hatch-Waxman Act</a></li> </ul> Questions or comments? Email us at <a href="mailto:comments@prescriptionforbetteraccess.com">comments@prescriptionforbetteraccess.com</a>. Find us on social media! Follow us on <a href="https://twitter.com/RX4BetterAccess">X</a>, <a href="https://www.linkedin.com/in/rxbetteraccess/">LinkedIn</a>, <a href="https://www.youtube.com/channel/UCYmufvyPSLLqaXWCfX7TiEw">YouTube</a> and <a href="https://www.threads.net/@prescriptionforbetteraccess">Threads</a>.

March 30, 2026

Spotlight on Rare Disease: A Conversation with Alexander Hardy, President and CEO, BioMarin

In this episode, we sit down with Alexander Hardy, President and CEO of BioMarin, to talk about his path to leading one of the world's premier rare disease companies. Alexander reflects on his experience across small molecules, biologics, oncology, and rare diseases, and how his work in access and patient services has shaped his thinking about leadership. We discuss the policy environment coming out of Washington — including the IRA and other pricing reforms — and how those factors influence long-term innovation and investment decisions. We also explore the real-world challenges facing rare disease patients, employer concerns about high-cost therapies, and what needs to change over the next five years to improve access and affordability. <ul> <li><a href="https://www.biomarin.com/company/leadership/alexander-hardy/">Alexander Hardy</a></li> <li><a href="https://www.bloomberg.com/profile/company/PGNS:US?embedded-checkout=true">PathoGenesis</a></li> <li><a href="https://www.lilly.com">Eli Lilly</a> | <a href="https://www.gsk.com/en-gb/">GSK</a> | <a href="https://www.novartis.com">Novartis</a></li> <li><a href="https://www.gene.com">Genentech</a> — <a href="https://www.genentech-access.com/hcp.html">Access Solutions</a></li> <li><a href="https://www.biomarin.com">BioMarin</a> — <a href="https://www.biomarin-rareconnections.com">Rare Connections</a></li> <li><a href="https://www.spencerfane.com/insight/congress-enacts-long-awaited-fix-to-orphan-drug-exclusivity-in-2026-consolidated-appropriations-act/">AUTHrd Act of 2026</a> (part of the <a href="https://www.congress.gov/bill/119th-congress/senate-bill/832/text">EPIC Act, HR 1492/S832</a>) — pending before Congress</li> <li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12534280/">Health Technology Assessments in Rare Diseases</a></li> </ul> Questions or comments? Email <a href="mailto:comments@prescriptionforbetteraccess.com">comments@prescriptionforbetteraccess.com</a>. Find us on <a href="https://twitter.com/RX4BetterAccess">X</a>, <a href="https://www.linkedin.com/in/rxbetteraccess/">LinkedIn</a>, <a href="https://www.youtube.com/channel/UCYmufvyPSLLqaXWCfX7TiEw">YouTube</a>, and <a href="https://www.threads.net/@prescriptionforbetteraccess">Threads</a>.

39 total episodes available

Similar Podcasts

Discover related shows you might enjoy

Pivot

New York Magazine

The Daily

The New York Times

Deep-dive analytics for Prescription for Better Access

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Prescription for Better Access?: With pharmaceutical and biotech manufacturers launching more high-cost specialty drugs and the insurance industry increasing the use of more restrictive barriers to access, those who need these medicines—the patients themselves—are caught in the middle, not only shouldering the cost of higher copays and deductibles, but for many, rationing or even abandoning treatment altogether.

While manufacturers invest in programs to help navigate the challenges impeding access and affordability, the entire healthcare industry can agree -- the status quo is unsustainable. There has to be a better way. And two industry veterans have joined forces to co-host a new interview-focused podcast to help shape the future of patient access and affordability.
How often does this podcast release new episodes?: This podcast updates bi-weekly.
Where can I listen to this podcast?: This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Information about guest appearances is not available.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.